The Form 4 filing, an SEC report of insider stock trades, was filed on November 12, 2026. It covers sales made from November 10 through November 12 by director Michael Stuart Klein.
Claritev Corp is listed in the healthcare sector and the health information services industry.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-10 |
| Date of Latest Transaction | 2026-11-12 |
| Buy/Sell | sell |
| Transaction Count | 3 |
| Shares Transacted | 65,567 |
| Price | $27.72 |
| Total Transaction Value | $1,817,754.93 |
| Insider | |
| Ticker Symbol | CTEV |
| Company | Claritev Corp |
| Insider Name | Klein Michael Stuart |
| Insider Title | Director |
| Sector - Industry | Healthcare - Health Information Services |
| Holdings | |
| Total Shares Owned After Transaction | 195,490 |
| Position Size Change | 25.12% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were sales of Claritev Corp (CTEV) shares by director Michael Stuart Klein. The three transactions carry code S, which identifies a sale.
What was the average price of the transaction?
The average sale price was $27.72 per share, rounded to the nearest cent. This average covers the 65,567 shares sold across the three reported transactions.
How did this transaction affect the insider's holdings?
The sales reduced his reported shares by 65,567, leaving 195,490 shares owned afterward. The shares sold made up 25.12% of the shares he owned before the sales.
What's the total transaction value?
The combined value of the three sales was $1,817,754.93, rounded to the nearest cent. The value before that rounding was $1,817,754.9312.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement for these sales. Filing footnotes were not available, so further details about any trading plan or other terms remain unknown.
For research purposes only; not investment advice.